What is the difference between somatic and germline mutations in Prostate Cancer

Somatic vs. Germline Mutations in Prostate Cancer

Great question—understanding the difference between these two types of mutations is important for treatment planning and family health considerations.

Germline Mutations: Inherited from Birth

Germline mutations are changes in your DNA that you inherited from one or both parents and are present in every cell in your body from birth. These mutations are passed down through families.

Key characteristics:

• Present in all your cells (blood, skin, prostate, etc.)
• Can be passed to your children
• Increase lifetime cancer risk
• Examples include BRCA1 and BRCA2 mutations (genes that normally help repair damaged DNA)
• Account for about 5-10% of prostate cancers

Why this matters for treatment: If you have a germline mutation like BRCA, this opens up specific treatment options. According to the CancerPatientLab webinar on advanced prostate cancer, PARP inhibitors (drugs that block DNA repair) can be especially effective against cancers with germline gene mutations affecting DNA repair, such as BRCA mutations.

---

Somatic Mutations: Acquired During Lifetime

Somatic mutations are changes in DNA that develop only in cancer cells during your lifetime—they are not inherited and are not present in your normal cells. These mutations happen randomly as cells divide.

Key characteristics:

• Occur only in the tumor itself
• Cannot be passed to children
• Develop due to aging, environmental factors, or random errors in cell division
• Account for the majority of prostate cancers
• Can vary between different tumors in the same person

---

Why This Distinction Matters for Your Care

For Treatment Planning: The webinar featuring Dr. [removed] Davis emphasizes the importance of genetic testing to identify these mutations. As mentioned in the discussion, one patient had genetic results showing potential efficacy with PARP inhibitors—this type of precision medicine approach depends on knowing whether mutations are germline or somatic.

For Your Family:

• Germline mutations mean your relatives should consider genetic counseling and testing
• Somatic mutations don't require family members to be tested

For Clinical Trials: Many advanced prostate cancer trials, as discussed in the immunotherapy webinar by Dr. [removed] Subudhi, are now using genomic profiling to match patients with appropriate treatments based on their specific mutations.

---

Questions to Ask Your Oncology Team

1. Have I had genetic testing to check for germline mutations (like BRCA)?
2. Has my tumor been tested for somatic mutations (like through Foundation One or similar testing)?
3. Based on my specific mutations, what treatment options are available to me?
4. If I have a germline mutation, should my family members be tested?
5. Are there clinical trials that match my specific genetic profile?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.